A Study of LY2623091 in Participants With High Blood Pressure
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and effectiveness of the study drug
known as LY2623091 in participants with high blood pressure.